Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update Life Science Investing
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights Life Science Investing
Cizzle Brands Corporation Announces Closing of US$6.2 Million Senior Secured Convertible Note Financing Biotech Investing
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026 Life Science Investing
Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance Life Science Investing
Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Life Science Investing
Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements Life Science Investing
